Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days postkidney transplantation
Publication

Publications

Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days postkidney transplantation

Title
Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days postkidney transplantation
Type
Article in International Scientific Journal
Year
2002
Authors
José Oliveira
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Xavier, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sampaio, SM
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Henriques, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Tavares, I
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Mendes, AA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pestana M
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: TransplantationImported from Authenticus Search for Journal Publications
Vol. 73
Pages: 915-920
ISSN: 0041-1337
Other information
Authenticus ID: P-000-Q01
Abstract (EN): Background. The new immunosuppressive drug Rapamycin (Rapa) is endowed with a mechanism of action that is distinct from that of calcineurin inhibitors. It has been claimed that Rapa does not significantly modulate either the cytokine expression or the transcription of several growth factors in mitogen-activated T cells. Previously, we reported that fine-needle aspiration biopsy (FNAB) sample cultures synthesize a large array of cytokines, and some of them may be powerful predictors of acute rejection in renal transplants. We hypothesized that Rapa may induce significant changes on cytokine production by FNAB sample cultures and on serum cytokine receptors when compared to other immunosuppressive drugs. Methods. Kidney transplants treated with CsA-Rapa-Pred (Rapa group) were compared with transplants treated with CsA-mycophenolate mofetil-Pred (MMF group). They were studied on day 7 posttransplantation, and they remained rejection free for at least the first 6 months. FNAB samples were cultured and the supernatants were collected at 48 hr of incubation and analyzed by ELISA for interleukin 1 receptor antagonist (IL-1ra), IL-2, IL-6, IL-10, IL-18, monocyte chemotactic protein 1 (MCP-1), soluble tumor necrosis factor 1, and transforming growth factor (TGF)-beta(1). The soluble receptors for IL-1, IL-2, IL-6, and tumor necrosis factor a, together with IL-2 and IL-18 were also measured in serum. Results. Significant differences were observed when comparing Rapa with the MMF group. IL-18 and TGF-beta(1) synthesis were up-regulated, whereas IL-6 and MCP-1 were down-regulated in FNAB sample cultures. The Rapa group showed a significant down-regulation of each cytokine receptor and of IL-2 in serum. Conclusions. Rapa was associated with a decreased synthesis of primarily monocyte-derived cytokines and enhanced production of TGF-beta(1), which in an appropriate cytokine milieu may promote allograft tolerance. The down-regulation of cytokine receptors and IL-2 may be associated with a depressed immune response towards the kidney allograft.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Inability of Mutant Transthyretin V30M to Cross the Blood-Eye Barrier (2012)
Another Publication in an International Scientific Journal
beirao, jm; moreira, lv; lacerda, pc; vitorino, rp; beirao, ib; torres, pa; costa, pp
Direct Downregulation of Toll-Like Receptors by Anti-IL-2 Alpha Chain-Receptor Antibody in Cadaver Kidney Transplant Recipients (2009)
Another Publication in an International Scientific Journal
Xavier, PDP; Alves, H; José Oliveira; Santos Araujo, CAR; Roncon-Albuquerque R Jr; Leite-Moreira AF; Ribeiro, ASL; Sampaio Norton, SMM
Common Vascular Endothelial Growth Factor Variants and Risk for Posttransplant Kaposi Sarcoma (2010)
Another Publication in an International Scientific Journal
Zanetti, E; Barozzi, P; Brown, EE; Bosco, R; Vallerini, D; Riva, G; Quadrelli, C; Potenza, L; Forghieri, F; Montagnani, G; D'Amico, R; Del Giovane, C; Duraes, C; Whitby, D; Machado JC; Schulz, TF; Torelli, G; Luppi, M
sTNFRI and sTNFRII synthesis by fine-needle aspiration biopsy sample cultures is significantly associated with acute rejection in kidney transplantation (2001)
Article in International Scientific Journal
José Oliveira; Xavier, P; Sampaio, SM; Mendes, AA; Pestana M
Oxidative Stress in Kidney Transplantation: Malondialdehyde Is an Early Predictive Marker of Graft Dysfunction (2014)
Article in International Scientific Journal
Isabel Fonseca; Henrique Reguengo; Manuela Almeida; Leonidio Dias; La Salete Martins; Sofia Pedroso; Josefina Santos; Luisa Lobato; Antonio Castro Henriques; Denisa Mendonca

See all (6)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-07 at 20:01:56 | Privacy Policy | Personal Data Protection Policy | Whistleblowing